Guangdong Transtek Medical Electronics (300562.SZ) has submitted a registration application for a blood glucose meter medical device, which has been accepted.
LeXin Pharmaceutical (300562.SZ) issued an announcement that the company recently received a notice from the Guangdong Provincial Drug Administration (referred to as...
Guangdong Transtek Medical Electronics (300562.SZ) announced that the company has recently received a notice from the Guangdong Provincial Drug Administration (referred to as "Guangdong Drug Administration") informing them that the registration application for the company's blood glucose meter medical device has been accepted.
The above-mentioned blood glucose meter product is composed of a host and software. This product is intended for use by diabetes patients at home, to quantitatively detect the concentration of glucose in fresh adult venous whole blood samples and capillary whole blood samples, monitoring the effectiveness of blood sugar control. The blood glucose meter GBZ41-B has Bluetooth function, allowing the measurement results to be uploaded to a designated app, making it easier for users to promptly view the health status of themselves and family members.
Related Articles

US Stock Market Move | Spot gold rose to $3250 as the gold sector rallied.

US Stock Market Move | Announce a new 20 billion euro buyback plan, Vodafone Group Plc Sponsored ADR (VOD.US) rises over 7%.

US Stock Market Move | Some countries are experiencing an upward trend in new cases of COVID-19. Moderna stock (MRNA.US) has risen by over 10%.
US Stock Market Move | Spot gold rose to $3250 as the gold sector rallied.

US Stock Market Move | Announce a new 20 billion euro buyback plan, Vodafone Group Plc Sponsored ADR (VOD.US) rises over 7%.

US Stock Market Move | Some countries are experiencing an upward trend in new cases of COVID-19. Moderna stock (MRNA.US) has risen by over 10%.

RECOMMEND